Biological Therapy in Treating Women With Metastatic Breast Cancer

Status unconfirmed · Phase 1/Phase 2

Conditions studied: Breast Cancer

In brief

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of T cells and interleukin-2 combined with peripheral stem cell transplantation or bone marrow transplantation in treating women who have stage IIIB or metastatic breast cancer.

Key facts

Study ID

NCT00002780

Run by

St. Luke's Medical Center

People needed

60

Starts

1996-05-01

Last updated by the study team

2013-12-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

Where it is running

• St. Luke's Medical Center — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.